SCHEMBL23183406

SCHEMBL23183406

N#Cc1c(C(F)F)cc(=O)[nH]c1SC1CNCCO1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23183460 0.82 KDM4E (0.48) —
SCHEMBL23183403 0.71 KDM4E (0.32) —
SCHEMBL20350858 0.68 ALDH1A1 (0.47) —
SCHEMBL20339837 0.64 KDM4E (0.57) —
SCHEMBL23183409 0.59 ALDH1A1 (0.41) —
SCHEMBL28160957 0.56 SLC6A2 (0.40) —
SCHEMBL4196229 0.55 KDM4E (0.38) —
SCHEMBL10346285 0.55 DRD2 (0.33) —
Morpholine SCHEMBL4918666 0.55 KDM4E (0.44) —
SCHEMBL612910 0.55 DRD2 (0.32) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11780812-B2 Oxopyridine derivatives useful as aminocarboxymuconate semialdehyde decarboxylase (ACMSD) inhibitors ORSOBIO, INC. (US) 2023-10-10 — — US disclosed
US-20210094916-A1 OXOPYRIDINE DERIVATIVES USEFUL AS AMINOCARBOXYMUCONATE SEMIALDEHYDE DECARBOXYLASE (ACMSD) INHIBITORS ORSOBIO, INC. 2021-04-01 — — US disclosed
Send feedback